Global Cardiac Troponin Market Size, Shares, Trends

The cardiac troponin market refers to the industry encompassing the development, manufacturing, and distribution of tests and assays used for detecting and measuring cardiac troponin levels in the blood. Cardiac troponin (cTn) is a set of regulatory proteins unique to cardiac muscle, plays a crucial role in muscle contraction and relaxation. It serves as a specific biomarker for myocardial damage for the diagnosis of myocardial infarction (MI). Technological advancements, including the development of fully automated labs and product innovation, aid in propelling the market growth of cardiac troponin. Further, the integration of AI and machine learning into troponin testing for detecting the minuscule elevations in troponin levels during the early stages of a suspected heart attack is escalating the market growth opportunity. The growing prevalence of cardiovascular diseases is driving the demand for cardiac troponin for optimizing risk stratification in patients with chronic coronary artery disease. However, the lack of sensitivity of conventional assays for detecting the presence of small amounts of this protein is restraining the cardiac troponin market.